ST Germain D J Co. Inc. Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

ST Germain D J Co. Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,560 shares of the healthcare conglomerate’s stock after selling 524 shares during the period. ST Germain D J Co. Inc.’s holdings in UnitedHealth Group were worth $8,673,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Waycross Partners LLC increased its stake in UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares during the period. Sherbrooke Park Advisers LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $515,000. Full Sail Capital LLC increased its stake in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after buying an additional 33 shares during the period. Soros Fund Management LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $39,413,000. Finally, Silvercrest Asset Management Group LLC increased its stake in shares of UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after buying an additional 12,550 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.8%

UnitedHealth Group stock opened at $304.27 on Tuesday. The stock has a market cap of $276.01 billion, a PE ratio of 19.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a fifty day moving average of $426.60 and a 200 day moving average of $490.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the company posted $6.91 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research analyst reports. Barclays reduced their target price on UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a research note on Monday. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a report on Monday. Finally, Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $439.17.

Read Our Latest Stock Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.